Stoke Therapeutics Inc (STOK)

SG&A Expense Growth

23.02%

Quarterly · Period ending:

STOK logo

STOK SG&A Expense Growth

Latest reported23.02%
STOK Quarterly SG&A Growth (QoQ) (0.00% → 23.02%)
High-resolution chart · PNG

STOK sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
23.0249%
-2.5468%
32.4031%
1.4284%
4.1561%
14.0844%
1.1976%
1.7395%
29.0072%
-3.4834%
3.2035%
0.3515%
0.1346%
9.2873%
-6.0374%
-1.7749%
5.1488%
4.4131%
4.7928%
4.9281%
14.7527%
21.6825%
1.4281%
11.0626%
11.5929%
13.5964%
19.7052%
37.2419%
10.6441%
42.3277%
41.1009%
-2.852%
70%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.